Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis. 1997

N V Naoumov, and S Chokshi, and E Metivier, and G Maertens, and P J Johnson, and R Williams
Institute of Liver Studies, King's College School of Medicine and Dentistry, London, UK.

OBJECTIVE The role of hepatitis C virus replication and different genotypes in the progression of cirrhosis to hepatocellular carcinoma is examined on the basis of a prospective follow-up of 1438 patients with histologically proven cirrhosis. METHODS The presence of HCV RNA, anti-HCV and characterisation of virus genotypes were determined in 72 cases who developed hepatocellular carcinoma after a median follow-up of 5.3 years (range 1 to 16) and compared to 72 controls who had cirrhosis only, after a median follow-up of 4.8 years (range 1 to 16). Patients in the hepatocellular carcinoma group and controls were matched, one to one, for age, sex, nationality, HBsAg seropositivity, duration of follow-up and aetiology of cirrhosis. RESULTS HCV RNA was detected in 31 of 72 (44%) patients who developed hepatocellular carcinoma, significantly more frequently than in 17 of 72 (23%) controls with cirrhosis (odds ratio 2.4, 95% confidence interval 1.2 to 5.0; p = 0.013). When cirrhosis of different aetiologies was analysed, hepatitis C virus replication was more frequently detected in patients developing hepatocellular carcinoma in association with cryptogenic cirrhosis (p = 0.007), alcoholic cirrhosis (p = 0.043) and hepatitis B virus seronegative cirrhosis (p = 0.05). Hepatitis C virus genotypes 1b and 4 were the most prevalent; they were found in 53% and 25%, respectively, of the patients studied, but were equally distributed between cirrhosis progressing to hepatocellular carcinoma and controls. CONCLUSIONS Persistent hepatitis C virus replication is closely associated with hepatocellular carcinoma development in cirrhosis, and there is no preferential role of individual hepatitis C virus genotypes.

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis

Related Publications

N V Naoumov, and S Chokshi, and E Metivier, and G Maertens, and P J Johnson, and R Williams
November 2001, Antiviral research,
N V Naoumov, and S Chokshi, and E Metivier, and G Maertens, and P J Johnson, and R Williams
January 1992, Transactions of the Royal Society of Tropical Medicine and Hygiene,
N V Naoumov, and S Chokshi, and E Metivier, and G Maertens, and P J Johnson, and R Williams
August 2010, World journal of gastroenterology,
N V Naoumov, and S Chokshi, and E Metivier, and G Maertens, and P J Johnson, and R Williams
June 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
N V Naoumov, and S Chokshi, and E Metivier, and G Maertens, and P J Johnson, and R Williams
March 1997, Hepatology (Baltimore, Md.),
N V Naoumov, and S Chokshi, and E Metivier, and G Maertens, and P J Johnson, and R Williams
July 2012, Journal of theoretical biology,
N V Naoumov, and S Chokshi, and E Metivier, and G Maertens, and P J Johnson, and R Williams
January 1993, Alcohol and alcoholism (Oxford, Oxfordshire). Supplement,
N V Naoumov, and S Chokshi, and E Metivier, and G Maertens, and P J Johnson, and R Williams
March 2005, Minerva gastroenterologica e dietologica,
N V Naoumov, and S Chokshi, and E Metivier, and G Maertens, and P J Johnson, and R Williams
August 2008, Clinics in liver disease,
N V Naoumov, and S Chokshi, and E Metivier, and G Maertens, and P J Johnson, and R Williams
September 1990, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!